Adagene Inc. (ADAG) stock
ADAGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.82+0.34 (+22.97%)
Close on Nov 18, 2026Market cap $107.80MP/E –Yield –
Adagene operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was -$21.44M. The highest annual figure on record is -$17.33M in fiscal 2018.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$21.44M | – |
| FY2024 | Dec 31, 2024 | -$35.95M | – |
| FY2023 | Dec 31, 2023 | -$23.72M | – |
| FY2022 | Dec 31, 2022 | -$83.92M | – |
| FY2021 | Dec 31, 2021 | -$72.36M | – |
| FY2020 | Dec 31, 2020 | -$43.15M | – |
| FY2019 | Dec 31, 2019 | -$19.17M | – |
| FY2018 | Dec 31, 2018 | -$17.33M | – |
See a number that looks wrong?